Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "66d999cc236afd258ed10348",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Nintedanib 100 mg",
"description": "NINTEDONE 100 \nNintedanib 100 mg is a cutting-edge oral medication designed to combat progressive lung conditions and certain cancers, offering hope to patients facing debilitating fibrotic diseases. As a small-molecule tyrosine kinase inhibitor, it targets key pathways involved in abnormal cell growth and tissue scarring, making it a vital therapy for idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and progressive fibrosing interstitial lung diseases (PF-ILD). Manufactured to high standards, this formulation delivers precise dosing in a convenient capsule form, ensuring consistent absorption and efficacy for long-term management.\n\nUses of Nintedanib 100 mg\nNintedanib 100 mg stands out for its approved indications in slowing the decline of lung function in adults with IPF, a chronic and fatal lung disease characterized by progressive scarring of lung tissue. It is also indicated for SSc-ILD, where it helps manage lung fibrosis associated with systemic sclerosis, and PF-ILD, covering other chronic fibrosing lung conditions with a progressive phenotype. Beyond pulmonary fibrosis, Nintedanib has shown utility in oncology, particularly when combined with docetaxel for second-line treatment of advanced non-small cell lung cancer (NSCLC) of adenocarcinoma tumor histology, inhibiting tumor angiogenesis and growth.\n\nThis medication addresses the underlying fibrotic processes by restricting fibroblast proliferation and migration, which are central to lung tissue damage. In clinical practice, physicians prescribe Nintedanib 100 mg for patients with confirmed diagnoses via high-resolution CT scans or lung biopsies, often after other treatments fail. Its versatility extends to off-label considerations in other cancers like pancreatic or colorectal, though primary use remains in respiratory fibrosis and lung cancer, providing a targeted approach where traditional therapies fall short.\n\nKey Benefits of Nintedanib 100 mg\nOne of the primary benefits of Nintedanib 100 mg is its proven ability to reduce the rate of forced vital capacity (FVC) decline, a key measure of lung function, by up to 50% in IPF patients compared to placebo in landmark trials. This translates to slower disease progression, fewer acute exacerbations, and improved quality of life, allowing patients to maintain daily activities longer. The oral administration enhances patient compliance, avoiding the need for infusions or hospital visits.\n\nSlows Fibrosis Progression: By inhibiting multiple tyrosine kinases, it curbs excessive scar tissue formation in the lungs, preserving respiratory capacity over time.\n\nAnti-Angiogenic Effects: In cancer settings, it blocks vascular endothelial growth factor receptors (VEGFR), reducing tumor blood supply and metastasis risk.\n\nBroad-Spectrum Kinase Inhibition: Targets fibroblast growth factor receptors (FGFR), platelet-derived growth factor receptors (PDGFR), and others, addressing multifaceted disease pathways.\n\nManageable Long-Term Use: Clinical data supports sustained benefits with dose adjustments, minimizing hospitalizations for respiratory failure.\n\nImproved Survival Metrics: In combination therapies for NSCLC, it extends progression-free survival, offering valuable time for patients.\n\nThese advantages make Nintedanib 100 mg a cornerstone in modern pulmonology and oncology, backed by phase III trials demonstrating statistically significant outcomes in diverse patient populations.\n\nSide Effects of Nintedanib 100 mg\nWhile effective, Nintedanib 100 mg can cause gastrointestinal side effects as the most common issue, affecting over 60% of users primarily due to its impact on kinase signaling in the gut. Diarrhea often starts within the first two weeks and is typically manageable with dose reduction or antidiarrheal agents like loperamide. Other frequent effects include nausea, vomiting, and decreased appetite, which may lead to weight loss if not addressed.\n\nMore serious side effects warrant close monitoring:\n\nLiver Enzyme Elevations: Hepatotoxicity occurs in about 10-15% of patients, necessitating monthly liver function tests, especially in those with pre-existing liver conditions.\n\nCardiovascular Risks: Potential for arterial thromboembolism or hypertension; baseline cardiac evaluation is recommended.\n\nBleeding Events: Due to VEGF inhibition, minor bleeding like epistaxis is common, but gastrointestinal hemorrhage requires immediate attention.\n\nRare but Severe: Interstitial lung disease progression (paradoxical worsening), perforations, or severe infections in immunocompromised patients.\n\nPatients should report persistent diarrhea, abdominal pain, jaundice, or unusual fatigue promptly. Contraindications include pregnancy (category D), active bleeding, or hypersensitivity, with strong recommendations against use in moderate to severe hepatic impairment.\n\nDosage and Administration Insights\nTypically initiated at 150 mg twice daily for IPF and ILD, Nintedanib 100 mg allows for flexible dosing—starting lower at 100 mg BID if tolerated poorly, with food to reduce GI upset. For NSCLC, it's 200 mg BID with docetaxel cycles. Regular monitoring every 2-3 months adjusts for tolerance, emphasizing adherence to slow disease modification.\n\nConclusion\nNintedanib 100 mg represents a breakthrough in managing progressive fibrotic lung diseases and select cancers, delivering targeted inhibition of fibrotic and angiogenic pathways for tangible clinical benefits. Its ability to slow FVC decline, enhance patient quality of life, and integrate into combination regimens underscores its value, despite manageable side effects like diarrhea that respond well to supportive care. For those battling IPF, SSc-ILD, or NSCLC, Nintedanib 100 mg offers a proactive defense against relentless progression, empowering longer, more active lives under specialist guidance.",
"price": 795.0,
"discountamount": 296.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"one capsule",
"weight loss",
"scar tissue",
"key players",
"Key Benefits",
"lung function",
"initial stages",
"abdominal pain",
"fibrous tissue",
"key ingredient",
"Bleeding Events",
"fibrotic tissue",
"daily activities",
"tyrosine kinases",
"fibrotic process",
"Nintedanib 100 mg",
"multiple pathways",
"active ingredient",
"sudden worsenings",
"crucial medication",
"recommended dosage",
"Decreased Appetite",
"signaling pathways",
"multiple receptors",
"overall well-being",
"disease progression",
"acute exacerbations",
"healthcare provider",
"Common side effects",
"elevated liver enzymes",
"Gastrointestinal Issues",
"other fibrotic diseases",
"Liver Enzyme Elevations",
"tyrosine kinase inhibitor",
"progressive lung conditions",
"other fibrotic lung diseases",
"idiopathic pulmonary fibrosis",
"potent pharmaceutical formulation",
"fibroblast growth factor receptor",
"platelet-derived growth factor receptor",
"vascular endothelial growth factor receptor"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1971,
"imageuri": "https://productimages.withfloats.com/actual/66d999d4f2036c2969cdeca8.png",
"tileimageuri": "https://productimages.withfloats.com/tile/66d999d4f2036c2969cdeca8.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-09-05T11:45:16.665Z",
"updatedon": "2026-03-14T06:46:45.85Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/nintedanib-100-mg/1971",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "NINTEDONE 100 ",
"category": "NEPHROLOGYRANGE",
"tags": [
"lung conditions and certain cancers",
"Nintedanib 100 mg",
"pulmonary fibrosis (IPF)",
"fibrosis and lung cancer",
"nintedanib 100 mg",
"nintedanib capsules 100 mg",
"nintedanib 100 mg capsules",
"nintedanib 100 mg medicine",
"nintedanib 100 mg tablet uses",
"what is nintedanib 100 mg used for",
"how nintedanib 100 mg works",
"nintedanib 100 mg uses and benefits",
"nintedanib 100 mg for lung disease",
"nintedanib 100 mg for pulmonary fibrosis",
"nintedanib 100 mg for idiopathic pulmonary fibrosis",
"nintedanib 100 mg for interstitial lung disease",
"nintedanib capsules for chronic lung disease",
"nintedanib 100 mg price in india",
"nintedanib 100 mg capsules price",
"buy nintedanib 100 mg online",
"nintedanib 100 mg supplier india",
"nintedanib 100 mg manufacturer",
"when should nintedanib 100 mg be taken",
"who should take nintedanib 100 mg",
"can nintedanib slow lung fibrosis",
"how long to take nintedanib 100 mg",
"does nintedanib cure pulmonary fibrosis"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "66618cb9ea22b014e8af26c2",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Nintedanib 150",
"description": "NINTENDO 150\nNintedone 150 is a prescription medicine containing Nintedanib 150 mg, an advanced targeted therapy widely used in the management of certain chronic and progressive lung diseases and specific types of cancer. It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which work by slowing disease progression at a cellular level.\n\nProgressive lung disorders such as Idiopathic Pulmonary Fibrosis (IPF) and other fibrosing interstitial lung diseases can significantly affect breathing capacity, quality of life, and long-term health outcomes. Nintedone 150 plays a crucial role in managing these conditions by reducing the rate of lung function decline and controlling abnormal tissue growth. Due to its disease-modifying potential, it is considered a cornerstone therapy in modern pulmonary and oncology care.\n\nProduct Composition\n\nActive Ingredient: Nintedanib 150 mg\n\nBrand Name: Nintedone 150\n\nDosage Form: Oral capsule\n\nNintedanib acts by inhibiting multiple growth factor receptors involved in disease progression, including vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF).\n\nUses of Nintedone 150\n\nNintedone 150 is prescribed for the following medical conditions:\n\nIdiopathic Pulmonary Fibrosis (IPF)\nHelps slow down the progressive scarring of lung tissue and preserves lung function over time.\n\nChronic Fibrosing Interstitial Lung Diseases (ILDs)\nUsed in patients with progressive fibrosing lung disorders associated with autoimmune or environmental causes.\n\nSystemic Sclerosis-Associated ILD\nReduces lung fibrosis progression in patients suffering from systemic sclerosis.\n\nCertain Types of Cancer (Oncological Use)\nIn some cases, Nintedanib is used in combination with chemotherapy for specific lung cancers under specialist supervision.\n\nHow the Nintendo 150 Works\n\nNintedone 150 works by blocking multiple signaling pathways responsible for:\n\nExcessive fibrous tissue formation\n\nAbnormal blood vessel growth\n\nInflammatory cell activity\n\nBy inhibiting tyrosine kinase receptors, the medicine slows the process of fibrosis and tumor growth. Rather than reversing damage, Nintedone 150 helps delay disease progression, making early diagnosis and consistent treatment extremely important.\n\nKey Benefits of Nintedone 150\n\nSlows Lung Function Decline\nClinical studies have shown that Nintedanib significantly reduces the rate of forced vital capacity (FVC) decline in IPF and ILD patients.\n\nDisease Progression Control\nHelps manage progressive fibrosing lung diseases where limited treatment options are available.\n\nImproves Long-Term Outcomes\nWhile it does not cure the disease, it enhances long-term stability and preserves respiratory function.\n\nTargeted Action\nWorks at the molecular level, offering precise control over disease-causing pathways.\n\nOnce-Daily or Twice-Daily Regimen\nSimplifies long-term treatment adherence under medical supervision.\n\nOncology Support\nProvides additional benefits in selected cancer treatment protocols when combined with other therapies.\n\nDosage and Administration\n\nThe usual recommended dose is Nintedone 150 mg twice daily, taken approximately 12 hours apart.\n\nCapsules should be swallowed whole with water.\n\nIt is advised to take the medicine with food to reduce gastrointestinal side effects.\n\nDosage adjustments may be required based on tolerability, liver function, or side effects.\n\n⚠️ Always follow your doctor’s instructions. Do not change the dose or stop the medicine without medical advice.\n\nPossible Side Effects\n\nLike all medicines, Nintedone 150 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects\n\nDiarrhea\n\nNausea or vomiting\n\nAbdominal pain\n\nDecreased appetite\n\nWeight loss\n\nFatigue\n\nLess Common but Serious Side Effects\n\nElevated liver enzymes\n\nLiver function impairment\n\nBleeding complications\n\nHigh blood pressure\n\nCardiovascular events (rare)\n\nIf side effects become severe or persistent, immediate medical consultation is necessary. Early management often helps continue therapy safely.\n\nPrecautions and Warnings\n\nLiver Disorders: Regular liver function monitoring is essential.\n\nPregnancy and Breastfeeding: Not recommended due to potential risk to the fetus or infant.\n\nBleeding Risk: Use cautiously in patients on anticoagulant therapy.\n\nSmoking: Smoking may reduce the effectiveness of Nintedanib.\n\nDrug Interactions: Inform your doctor about all medicines and supplements you are taking.\n\nWho Should Avoid Nintedone 150\n\nPatients with severe liver impairment\n\nPregnant or breastfeeding women\n\nIndividuals with known hypersensitivity to Nintedanib\n\nPatients with uncontrolled bleeding disorders\n\nStorage Instructions\n\nStore below 25°C in a cool, dry place.\n\nProtect from moisture and direct sunlight.\n\nKeep out of reach of children.\n\nConclusion\n\nNintedone 150 (Nintedanib 150 mg) represents a major advancement in the treatment of progressive lung diseases and selected oncological conditions. Its targeted mechanism helps slow disease progression, preserve lung function, and improve long-term patient outcomes when used consistently under medical supervision.\n\nWhile it does not cure fibrotic lung diseases, Nintedone 150 offers hope, stability, and better disease control, making it an essential therapy for patients facing chronic and life-limiting conditions. With proper monitoring, adherence, and medical guidance, it plays a vital role in modern respiratory and oncology care.",
"price": 984.0,
"discountamount": 344.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"IPF",
"ILDs",
"food",
"lungs",
"drugs",
"Email",
"class",
"ORDER",
"nausea",
"dosage",
"severe",
"doctor",
"SSc-ILD",
"appetite",
"WhatsApp",
"vomiting",
"diarrhea",
"formation",
"treatment",
"NINTEDONE",
"same times",
"medication",
"supervision",
"progression",
"scar tissue",
"prescription",
"instructions",
"sterispharma",
"sterisonline",
"effectiveness",
"lung function",
"abdominal pain",
"specific enzymes",
"healthcare provider",
"Common side effects",
"additional monitoring",
"healthcare professional",
"persistent side effects",
"liver enzyme elevations",
"Nintedanib 150mg tablets",
"tyrosine kinase inhibitors",
"idiopathic pulmonary fibrosis",
"chronic fibrosing interstitial lung diseases",
"systemic sclerosis-associated interstitial lung disease"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1448,
"imageuri": "https://productimages.withfloats.com/actual/66618cbd0c19ea48b9484a3b.png",
"tileimageuri": "https://productimages.withfloats.com/tile/66618cbd0c19ea48b9484a3b.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-06T10:17:29.618Z",
"updatedon": "2026-05-01T11:20:07.105Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//nintedanib-150/1448",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "NINTEDONE 150",
"category": "Oncology",
"tags": [
"NINTEDONE 150",
"Nintedanib (150mg)",
"Nintedanib 150 mg price in India",
"Nintedanib 150 mg generic medicine",
"Nintedanib 150 mg brands in India",
"Nintedanib 150 mg side effects",
"lung diseases and specific types of cancer.",
"Uses of Nintedone 150",
"Abnormal blood vessel growth",
"Reduces lung fibrosis progression in patients suffering from systemic sclerosis."
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "662b9f97a4eb611de48dd113",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Nintedanib 150 mg",
"description": "\nIntroduction to Nintedanib 150 mg\n\nNintedanib 150 mg is a widely prescribed medicine used in the management of serious lung conditions that cause progressive scarring and breathing difficulties. It belongs to a class of medicines known as tyrosine kinase inhibitors, designed to slow down the progression of lung fibrosis and improve overall respiratory health. Doctors commonly recommend Nintedanib 150 mg for patients suffering from conditions such as idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases (ILDs), and systemic sclerosis-associated interstitial lung disease.\n\nPatients searching for an effective medicine to manage worsening lung fibrosis often choose Nintedanib 150 mg because of its clinically proven effectiveness in slowing disease progression. With growing awareness about pulmonary fibrosis treatment, this medicine has become an important therapeutic option in respiratory care.\n\nWhat is Nintedanib 150 mg?\nf(x)=e\n−kx\nA\nk\ny=Ae\n−kt\n≈6e\n−0.6t\ny\nt\n\nNintedanib 150 mg capsules are oral prescription medicines formulated to reduce the rate of decline in lung function. It works by blocking pathways responsible for abnormal tissue scarring in the lungs. The medicine helps prevent further fibrosis and supports patients in maintaining better breathing capacity over time.\n\nNintedanib is mainly prescribed for:\n\nIdiopathic Pulmonary Fibrosis (IPF)\nProgressive Fibrosing Interstitial Lung Disease (PF-ILD)\nSystemic Sclerosis-Associated ILD\nCertain chronic pulmonary disorders involving fibrosis\n\nThe medicine is generally taken twice daily or as directed by a healthcare professional.\n\nHow Does Nintedanib 150 mg Work?\n\nNintedanib 150 mg works by inhibiting multiple growth factor receptors involved in fibrosis formation. These receptors are responsible for the excessive production of fibrous tissue inside the lungs. By blocking these signals, the medicine slows the progression of lung scarring.\n\nThis mechanism helps in:\n\nSlowing lung function decline\nReducing fibrosis progression\nImproving breathing stability\nSupporting long-term respiratory health\n\nUnlike medicines that only relieve symptoms, Nintedanib focuses on controlling the progression of the disease itself.\n\nKey Benefits of Nintedanib 150 mg\n1. Slows Disease Progression\n\nOne of the major advantages of Nintedanib 150 mg is its ability to reduce the speed at which lung scarring worsens. This is especially important for patients with progressive pulmonary fibrosis.\n\n2. Helps Maintain Lung Function\n\nRegular use may help preserve lung capacity and improve the patient’s ability to perform daily activities with reduced breathlessness.\n\n3. Clinically Proven Therapy\n\nNintedanib has been extensively studied in clinical trials and is considered an effective treatment option for fibrotic lung diseases.\n\n4. Oral Capsule Form\n\nThe medicine is easy to administer in capsule form, making treatment more convenient for long-term use.\n\n5. Supports Quality of Life\n\nBy slowing disease progression, patients may experience better mobility, reduced respiratory complications, and improved overall quality of life.\n\nUses of Nintedanib 150 mg\nIdiopathic Pulmonary Fibrosis (IPF)\n\nIPF is a chronic lung disease that causes gradual scarring of lung tissue. Nintedanib helps slow the worsening of this condition.\n\nProgressive Fibrosing ILD\n\nPatients with fibrosing interstitial lung diseases may benefit from reduced progression and stabilized respiratory performance.\n\nSystemic Sclerosis-Associated ILD\n\nNintedanib is also prescribed for lung complications related to systemic sclerosis, an autoimmune disorder.\n\nChronic Lung Fibrosis Management\n\nDoctors may recommend Nintedanib 150 mg for other chronic pulmonary fibrosis conditions requiring anti-fibrotic treatment.\n\nDosage and Administration\n\nNintedanib 150 mg should always be taken exactly as prescribed by the healthcare provider.\n\nGeneral Dosage Guidelines\nUsually taken twice daily\nSwallow capsules whole with water\nPreferably taken with food\nMaintain a consistent dosing schedule\n\nPatients should not crush, chew, or open the capsules unless advised by a medical professional.\n\nImportant Precautions Before Using Nintedanib 150 mg\n\nBefore starting treatment, patients should inform their doctor about:\n\nLiver disorders\nHeart disease\nBleeding disorders\nRecent surgeries\nPregnancy or breastfeeding\nExisting medications or supplements\n\nRoutine monitoring may be required during treatment to assess liver function and overall health status.\n\nPossible Side Effects of Nintedanib 150 mg\n\nLike all medicines, Nintedanib 150 mg may cause side effects in some patients. Most side effects are manageable with proper medical supervision.\n\nCommon Side Effects\nDiarrhea\nNausea\nVomiting\nAbdominal pain\nLoss of appetite\nWeight loss\nSerious Side Effects\n\nSeek immediate medical attention if you notice:\n\nSevere liver problems\nChest pain\nUnusual bleeding\nSevere allergic reactions\nDifficulty breathing\n\nPatients should immediately consult their doctor if side effects become persistent or severe.\n\nWhy Patients Choose Nintedanib 150 mg\n\nPatients and healthcare professionals prefer Nintedanib 150 mg due to its targeted anti-fibrotic action and long-term clinical benefits. It addresses the root mechanism of fibrosis progression rather than only symptom management.\n\nKey reasons behind its growing demand include:\n\nProven effectiveness in IPF treatment\nImproved respiratory stability\nBetter long-term disease management\nTrusted anti-fibrotic therapy\nWidely recommended by specialists\nStorage Instructions\n\nTo maintain medicine effectiveness:\n\nStore below recommended temperature\nKeep away from direct sunlight\nProtect from moisture\nKeep out of reach of children\n\nAlways check the packaging for detailed storage guidelines.\n\nWho Should Avoid Nintedanib 150 mg?\n\nNintedanib may not be suitable for everyone. Patients with severe liver disease, high bleeding risk, or known hypersensitivity should avoid using this medicine unless specifically advised by a healthcare professional.\n\nPregnant women should avoid this medicine due to potential risks to the unborn baby.\n\nDrug Interactions\n\nNintedanib 150 mg may interact with certain medicines, including:\n\nBlood thinners\nAntibiotics\nAntifungal medicines\nLiver enzyme affecting drugs\nHerbal supplements\n\nAlways provide a complete medication history to the doctor before starting treatment.\n\nFrequently Asked Questions About Nintedanib 150 mg\nIs Nintedanib 150 mg used for lung fibrosis?\n\nYes, it is primarily used for treating pulmonary fibrosis and related lung disorders.\n\nCan Nintedanib cure pulmonary fibrosis?\n\nNo, it does not cure the disease but helps slow down disease progression.\n\nHow long should Nintedanib be taken?\n\nTreatment duration depends on the patient’s condition and doctor’s recommendation.\n\nCan I stop taking Nintedanib suddenly?\n\nDo not stop treatment without consulting your healthcare provider.\n\nIs Nintedanib a chemotherapy medicine?\n\nNo, it is an anti-fibrotic medicine used mainly for lung diseases.\n\nConclusion\n\nNintedanib 150 mg is an advanced anti-fibrotic medicine widely used for managing progressive lung diseases such as idiopathic pulmonary fibrosis and interstitial lung disorders. Its ability to slow fibrosis progression and preserve lung function makes it an important treatment option for patients seeking long-term respiratory support.",
"price": 1050.0,
"discountamount": 150.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"ILD",
"IPF",
"part",
"scarring",
"pathways",
"mechanism",
"NINTEDONE",
"Nintedanib",
"lung tissue",
"inflammation",
"lung function",
"150mg strength",
"targeted medication",
"disease progression",
"prescription medicine",
"various lung diseases",
"healthcare professionals",
"comprehensive treatment plan",
"idiopathic pulmonary fibrosis",
"other interstitial lung diseases"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 771,
"imageuri": "https://productimages.withfloats.com/actual/662b9f99326a2039bea2891b.png",
"tileimageuri": "https://productimages.withfloats.com/tile/662b9f99326a2039bea2891b.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-04-26T12:35:35.162Z",
"updatedon": "2026-05-20T06:37:55.747Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//nintedanib-150-mg/771",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "NINTEDONE 150",
"category": "NEPHROLOGYRANGE",
"tags": [
"Nintedanib 150 mg",
"nintedanib 150 mg uses",
"nintedanib 150 mg uses in hindi",
"nintedanib 150 mg price",
"nintedanib 150 mg price in india",
"nintedanib 150 mg side effects",
"tab nintedanib 150 mg price",
"tab nintedanib 150 mg uses in hindi",
"tab nintedanib 150 mg uses",
"nintedanib 150 mg tablet",
"side effects of nintedanib 150 mg",
"nintedanib 150 mg brands in india",
"nintedanib 150 mg cost"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "68272992e579986392b124bf",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Nintedanib 150mg",
"description": "NINTEPRIDE 150 is a prescription medication that contains Nintedanib 150 mg, a targeted therapy used primarily in the treatment of idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and certain types of non-small cell lung cancer (NSCLC). It works by slowing the progression of fibrotic diseases, helping to maintain better lung function and improving the patient's quality of life.\n\nKey Ingredient\nNintedanib (150 mg)\nNintedanib is a tyrosine kinase inhibitor that blocks several growth factor receptors responsible for promoting fibrosis and tumor growth. It is an orally administered compound used in chronic and progressive lung conditions.\n\nKey Benefits\nHelps slow down the progression of idiopathic pulmonary fibrosis (IPF).\n\nImproves lung function and delays further decline in lung capacity.\n\nUsed as a treatment for systemic sclerosis-associated interstitial lung disease (SSc-ILD).\n\nBeneficial in certain types of advanced non-small cell lung cancer (NSCLC).\n\nTargets multiple pathways involved in fibrosis and tumor progression.\n\nProvides a convenient oral dosage form for chronic conditions.\n\nHow Does It Work?\nNINTEPRIDE 150 (Nintedanib 150 mg) works by inhibiting multiple receptor tyrosine kinases, including those for platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and vascular endothelial growth factor (VEGF). These growth factors are responsible for the development and progression of fibrosis and abnormal cell proliferation. By blocking these receptors, Nintedanib helps to:\n\nReduce the formation of scar tissue in the lungs.\n\nDecrease inflammation and tissue remodeling.\n\nInhibit tumor angiogenesis in certain cancer types.\n\nPreserve lung structure and function over time.\n\nDirections for Use\nNINTEPRIDE 150 should be taken orally, twice daily (usually one capsule in the morning and one in the evening).\n\nTake the capsule with food and water to reduce the risk of gastrointestinal side effects.\n\nDo not chew or crush the capsule; swallow it whole.\n\nTake the medication at the same times each day for optimal results.\n\nFollow the dosage and schedule prescribed by your healthcare provider.\n\nIf a dose is missed, skip it and continue with the next scheduled dose. Do not take a double dose.\n\nSide Effects\nNINTEPRIDE 150 may cause some common and serious side effects. It is important to report any persistent or severe symptoms to a healthcare professional.\n\nCommon Side Effects:\n\nDiarrhea\n\nNausea\n\nVomiting\n\nLoss of appetite\n\nWeight loss\n\nAbdominal pain\n\nLiver enzyme elevation\n\nSerious Side Effects:\n\nSevere liver problems\n\nBleeding complications\n\nGastrointestinal perforation\n\nHeart-related issues such as increased blood pressure or myocardial infarction\n\nHypersensitivity reactions including rash, itching, or swelling\n\nRegular liver function monitoring and clinical follow-up are essential while on NINTEPRIDE 150 to ensure safe and effective use.",
"price": 987.0,
"discountamount": 487.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"nintepride 150",
"tumor progression",
"capsule swallow",
"promoting fibrosis",
"nintepride 150nintepride 150",
"scheduled dose",
"chronic conditions",
"lung function",
"prescription medication",
"ensure safe",
"clinical followup",
"rash itching",
"severe symptoms",
"missed skip",
"healthcare provider",
"schedule prescribed",
"time directions",
"scar tissue",
"growth factors",
"lung capacity",
"tumor growth",
"patients quality",
"targeted therapy",
"nintedanib 150 mg",
"side effects",
"gastrointestinal side effects",
"orally administered compound",
"receptors nintedanib helps",
"increased blood pressure",
"optimal results follow",
"lungs decrease inflammation",
"abnormal cell proliferation",
"tyrosine kinase inhibitor",
"fibrotic diseases helping"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2116,
"imageuri": "https://productimages.withfloats.com/actual/682729941972da8c8f537bca.png",
"tileimageuri": "https://productimages.withfloats.com/tile/682729941972da8c8f537bca.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-05-16T12:03:30.781Z",
"updatedon": "2026-04-30T08:13:06.722Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//nintedanib-150mg/2116",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "NINTEPRIDE 150",
"category": "NEPHROLOGYRANGE",
"tags": [
"Nintedanib 150 mg",
"Nintedanib 150 mg price in India",
"Nintedanib 150 mg brands in India",
"Nintedanib 150 mg side effects",
"nintedanib soft gelatin capsules",
"nintedanib soft gelatin capsules uses in hindi",
"nintedanib soft gelatin capsules 150 mg",
"nintedanib soft gelatin capsules 150 mg",
"nintedanib soft gelatin capsules 150mg uses",
"nintedanib soft gelatin capsules 150mg price",
"rx nintedanib soft gelatin capsules",
"nintedanib soft gelatin capsules 150 mg price India",
"nintedanib 150 mg twice daily dosage schedule",
"buy nintedanib 150 mg soft gelatin capsules online",
"nintedanib 150 mg capsules price per strip",
"Nindanib 150 soft gelatin capsule buy online"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "66695161c91739182c954a1d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Pirfenidone 200mg",
"description": "Introduction\n\nRespiratory diseases affecting lung tissue have become a growing global concern due to increasing pollution, smoking habits, occupational exposure, infections, and age-related lung degeneration. One such serious chronic condition is Idiopathic Pulmonary Fibrosis (IPF), which leads to progressive scarring (fibrosis) of lung tissue, making breathing increasingly difficult over time.\n\nPirfenidone 200 mg is an antifibrotic and anti-inflammatory medicine widely used in the management of Idiopathic Pulmonary Fibrosis (IPF). It helps slow disease progression, reduce lung tissue scarring, and improve overall respiratory function when used under strict medical supervision.\n\nThis comprehensive SEO and GEO-optimized guide explains Pirfenidone 200 mg in detail, including its uses, mechanism of action, key benefits, side effects, precautions, and clinical relevance for patients and healthcare providers.\n\nWhat is Pirfenidone 200 mg?\n\nPirfenidone 200 mg is an oral antifibrotic medication used primarily for the treatment of Idiopathic Pulmonary Fibrosis (IPF), a chronic and progressive lung disease characterized by thickening and scarring of lung tissue.\n\nIt is classified as a lung fibrosis treatment drug that works by reducing fibroblast activity and slowing down the formation of scar tissue in the lungs.\n\nPirfenidone does not cure IPF but plays a crucial role in:\n\nSlowing disease progression\nPreserving lung function\nImproving quality of life\nReducing respiratory decline\nHow Does Pirfenidone 200 mg Work?\n\nPirfenidone works through multiple biological pathways involved in fibrosis and inflammation.\n\n1. Anti-Fibrotic Action\n\nPirfenidone helps inhibit the production of fibroblasts, which are cells responsible for forming scar tissue in the lungs. By controlling fibroblast activity, it slows the progression of lung fibrosis.\n\n2. Anti-Inflammatory Effect\n\nIt reduces inflammatory mediators such as cytokines that contribute to chronic lung inflammation and tissue damage.\n\n3. Reduction of Collagen Formation\n\nPirfenidone helps decrease excess collagen deposition in lung tissues, which is a key factor in pulmonary fibrosis.\n\n4. Oxidative Stress Reduction\n\nIt also reduces oxidative stress in lung cells, protecting them from further damage caused by free radicals.\n\nMechanism of Action of Pirfenidone 200 mg\n\nPirfenidone acts at the cellular level by modulating growth factors and cytokines involved in fibrosis, including:\n\nTransforming Growth Factor Beta (TGF-β)\nTumor Necrosis Factor Alpha (TNF-α)\nPlatelet-Derived Growth Factor (PDGF)\n\nBy regulating these pathways, Pirfenidone helps:\n\nSlow fibroblast proliferation\nReduce extracellular matrix buildup\nImprove lung tissue stability\nPreserve pulmonary function over time\nUses of Pirfenidone 200 mg\n\nPirfenidone 200 mg is primarily used in the management of:\n\n1. Idiopathic Pulmonary Fibrosis (IPF)\n\nThe main approved indication for Pirfenidone is IPF, a serious chronic lung condition that causes progressive scarring of lung tissue.\n\n2. Chronic Interstitial Lung Disease (ILD)\n\nIt may be used in certain cases of interstitial lung disease under medical supervision.\n\n3. Progressive Pulmonary Fibrosis\n\nHelps slow down progression of fibrosis in selected patients.\n\n4. Supportive Respiratory Therapy\n\nUsed as part of long-term treatment plans for maintaining lung function.\n\nKey Benefits of Pirfenidone 200 mg\n1. Slows Progression of Lung Fibrosis\n\nPirfenidone helps slow down the worsening of lung scarring in IPF patients.\n\n2. Improves Lung Function Stability\n\nIt helps maintain Forced Vital Capacity (FVC), a key measure of lung performance.\n\n3. Reduces Inflammation in Lungs\n\nBy lowering inflammatory activity, it supports healthier lung tissue environment.\n\n4. Antifibrotic Protection\n\nPrevents excessive formation of fibrotic tissue in the lungs.\n\n5. Improves Quality of Life\n\nPatients may experience better breathing capacity and reduced disease burden.\n\n6. Delays Disease Progression\n\nClinical studies show Pirfenidone can delay progression of IPF when taken regularly.\n\n7. Supports Long-Term Respiratory Health\n\nHelps preserve lung function over extended periods when used continuously.\n\n8. Reduces Risk of Acute Exacerbations\n\nMay lower the frequency of sudden worsening of lung symptoms.\n\nWho Can Benefit from Pirfenidone 200 mg?\n\nPirfenidone is generally prescribed for:\n\nPatients diagnosed with Idiopathic Pulmonary Fibrosis\nAdults with progressive lung scarring conditions\nIndividuals with declining lung function due to fibrosis\nPatients under pulmonologist supervision\n\nIt is not a general cough or asthma medicine and must only be used under strict medical guidance.\n\nDosage Guidelines for Pirfenidone 200 mg\n\nThe dosage is strictly individualized and should be determined by a healthcare professional.\n\nGeneral Approach:\nStarted at low dose\nGradually increased over time\nTaken multiple times per day with food\nImportant Instructions:\nAlways take with meals to reduce stomach upset\nDo not skip or double doses\nFollow pulmonologist’s prescription strictly\nSide Effects of Pirfenidone 200 mg\n\nLike all prescription medicines, Pirfenidone may cause side effects in some patients.\n\nCommon Side Effects:\nNausea\nLoss of appetite\nFatigue\nHeadache\nDizziness\nIndigestion\nSkin rash or sensitivity to sunlight\nGastrointestinal Effects:\nVomiting\nDiarrhea\nAbdominal discomfort\nSerious Side Effects of Pirfenidone 200 mg\n\nSeek immediate medical attention if any of the following occur:\n\nSevere allergic reactions\nLiver function abnormalities\nYellowing of skin or eyes (jaundice)\nSevere skin reactions\nPersistent vomiting\nBreathing difficulty worsening unexpectedly\n\nRegular liver function monitoring is often recommended during treatment.\n\nPrecautions and Warnings\nLiver Disease\n\nPatients with liver impairment require careful monitoring.\n\nSun Sensitivity\n\nPirfenidone may increase sensitivity to sunlight; protective clothing and sunscreen are recommended.\n\nPregnancy and Breastfeeding\n\nUse only if clearly advised by a doctor.\n\nDrug Interactions\n\nInform your doctor about all medications being taken, especially:\n\nAntibiotics\nAntifungal drugs\nOther antifibrotic therapies\nRegular Monitoring\n\nLiver function tests and lung function tests may be required periodically.\n\nClinical Importance of Pirfenidone 200 mg\n\nPirfenidone is considered a cornerstone therapy in IPF management. Clinical trials have demonstrated its ability to:\n\nSlow decline in lung function\nImprove progression-free survival\nReduce fibrosis-related complications\n\nIt is widely recommended in international pulmonology guidelines for IPF treatment.\n\nWhy Pirfenidone 200 mg is Important in IPF Treatment\n\nIdiopathic Pulmonary Fibrosis is a progressive and life-limiting disease. Without treatment, lung function continues to deteriorate.\n\nPirfenidone plays a vital role by:\n\nTargeting fibrosis pathways\nReducing inflammation\nPreserving respiratory capacity\nSupporting long-term disease management\nFrequently Asked Questions (FAQs)\nWhat is Pirfenidone 200 mg used for?\n\nIt is mainly used to treat Idiopathic Pulmonary Fibrosis (IPF), a chronic lung disease causing scarring.\n\nDoes Pirfenidone cure pulmonary fibrosis?\n\nNo, it does not cure IPF but helps slow disease progression.\n\nHow should Pirfenidone 200 mg be taken?\n\nIt should be taken orally with food as prescribed by a doctor.\n\nWhat are the most common side effects?\n\nNausea, fatigue, loss of appetite, and skin sensitivity to sunlight.\n\nIs long-term use safe?\n\nYes, under medical supervision and regular monitoring.\n\nCan Pirfenidone improve breathing?\n\nIt may help stabilize lung function and slow breathing deterioration.\n\nConclusion\n\nPirfenidone 200 mg is a clinically important antifibrotic medication used in the management of Idiopathic Pulmonary Fibrosis (IPF). By reducing lung inflammation, slowing fibrosis progression, and preserving lung function, it plays a crucial role in improving long-term respiratory outcomes.\n\nAlthough it is not a cure, its ability to slow disease progression makes it a valuable treatment option for patients suffering from progressive lung scarring conditions. When used under expert medical supervision with proper monitoring, Pirfenidone 200 mg can significantly contribute to better disease control and improved quality of life.",
"price": 329.0,
"discountamount": 99.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"IPF",
"Call",
"rash",
"food",
"ORDER",
"Email",
"lungs",
"nausea",
"product",
"fatigue",
"WhatsApp",
"guidance",
"diarrhea",
"medicine",
"PIRFENOID",
"breathing",
"medication",
"absorption",
"information",
"tablet form",
"sterisonline",
"side effects",
"sterispharma",
"stomach upset",
"standard dosage",
"Pirfenidone 200mg",
"active ingredient",
"disease progression",
"healthcare professional",
"idiopathic pulmonary fibrosis"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1776,
"imageuri": "https://productimages.withfloats.com/actual/66695164c9162f54a1557073.png",
"tileimageuri": "https://productimages.withfloats.com/tile/66695164c9162f54a1557073.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-12T07:42:25.938Z",
"updatedon": "2026-06-09T11:32:12.197Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//pirfenidone-200mg/1776",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "PIRFENOID 200",
"category": "RESPIRTORYRANGE",
"tags": [
"PIRFENOID 200 price",
"PIRFENOID 200 usses",
"PIRFENOID 200 side effects",
"pirfenidone 200 mg dosage",
"Pirfenidone (200mg)",
"Pirfenidone 200 mg dosage",
"pirfenidone 200 mg uses in hindi"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6630e4904df3bb0cfcb8b675",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "formoterol fluticasone inhaler",
"description": "R/C AIRFLOW MAX F250 \nAIRFLOWMAX F250 is a combination inhaler designed to help people manage chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease. This inhaler contains two active medicines, formoterol and fluticasone, which work together to improve breathing and reduce inflammation in the airways. AIRFLOWMAX F250 provides long-lasting relief by relaxing airway muscles while simultaneously reducing swelling and irritation in the lungs.\n\nRespiratory diseases can significantly impact daily life by causing symptoms such as breathlessness, wheezing, chest tightness, and persistent coughing. AIRFLOWMAX F250 is specially formulated to help patients control these symptoms effectively and maintain better lung function over time.\n\nComposition and Mechanism of Action\n\nAIRFLOWMAX F250 combines two proven medications:\n\n1. Formoterol\n\nFormoterol is a long-acting bronchodilator that belongs to the class of medications known as long-acting beta-agonists (LABA). It works by relaxing the smooth muscles surrounding the airways in the lungs. This relaxation helps open up the air passages, allowing air to move more freely in and out of the lungs. As a result, patients experience relief from breathing difficulties and wheezing.\n\n2. Fluticasone\n\nFluticasone is a corticosteroid that helps reduce inflammation in the airways. Inflammatory swelling is one of the main causes of airway narrowing in respiratory conditions like asthma and COPD. By reducing inflammation, fluticasone helps prevent asthma attacks and improves overall breathing control.\n\nTogether, these two ingredients provide both immediate bronchodilation and long-term inflammation control, making AIRFLOWMAX F250 an effective maintenance therapy for chronic respiratory conditions.\n\nUses of AIRFLOWMAX F250\n\nThe AIRFLOWMAX F250 inhaler is primarily used in the treatment and long-term management of several respiratory conditions.\n\n1. Asthma Management\n\nAsthma is a chronic condition characterized by inflamed and narrowed airways. Patients often experience wheezing, coughing, breathlessness, and chest tightness. AIRFLOWMAX F250 helps control asthma symptoms and reduces the frequency of asthma attacks by improving airflow and reducing airway inflammation.\n\n2. Chronic Obstructive Pulmonary Disease (COPD)\n\nCOPD includes progressive lung diseases such as emphysema and chronic bronchitis. These conditions cause airflow obstruction and breathing difficulties. AIRFLOWMAX F250 helps manage COPD symptoms by improving lung capacity and reducing inflammation in the respiratory tract.\n\n3. Prevention of Breathing Difficulties\n\nRegular use of AIRFLOWMAX F250 helps prevent symptoms like shortness of breath, wheezing, and coughing, allowing patients to carry out daily activities with greater ease and comfort.\n\n4. Long-Term Respiratory Control\n\nThis inhaler is often prescribed as part of a long-term treatment plan to maintain stable respiratory health and reduce the need for emergency medication.\n\nKey Benefits of AIRFLOWMAX F250\n1. Dual-Action Formula\n\nAIRFLOWMAX F250 contains both a bronchodilator and a corticosteroid, providing comprehensive relief by addressing two major causes of respiratory symptoms—airway constriction and inflammation.\n\n2. Improved Breathing\n\nBy relaxing airway muscles and reducing swelling, the inhaler allows patients to breathe more easily and comfortably.\n\n3. Long-Lasting Symptom Control\n\nFormoterol provides long-acting bronchodilation, helping patients maintain better breathing for extended periods.\n\n4. Reduced Frequency of Asthma Attacks\n\nRegular use of AIRFLOWMAX F250 helps reduce the frequency and severity of asthma flare-ups.\n\n5. Enhanced Lung Function\n\nThe combination of medications improves overall lung performance and airflow.\n\n6. Better Quality of Life\n\nWith improved breathing and fewer symptoms, patients can maintain normal daily activities with greater confidence and comfort.\n\n7. Preventive Therapy\n\nAIRFLOWMAX F250 is suitable for long-term use as a maintenance therapy, helping prevent worsening of respiratory conditions.\n\nHow to Use AIRFLOWMAX F250\n\nAIRFLOWMAX F250 should be used exactly as prescribed by a healthcare professional. The inhaler delivers medication directly into the lungs for quick and effective action.\n\nGeneral usage guidelines include:\n\nShake the inhaler well before use.\n\nExhale gently before inhalation.\n\nPlace the mouthpiece in your mouth and press the inhaler while inhaling deeply.\n\nHold your breath for a few seconds to allow the medicine to settle in the lungs.\n\nRinse your mouth with water after using the inhaler to reduce the risk of throat irritation.\n\nPatients should always follow the instructions provided by their doctor or pharmacist.\n\nPossible Side Effects\n\nLike all medications, AIRFLOWMAX F250 may cause some side effects in certain individuals. However, not everyone experiences these effects.\n\nCommon Side Effects\n\nThroat irritation\n\nHoarseness of voice\n\nDry mouth\n\nMild headache\n\nCough\n\nLess Common Side Effects\n\nMuscle cramps\n\nPalpitations\n\nOral fungal infection (thrush)\n\nTremors\n\nRare but Serious Side Effects\n\nIn rare cases, patients may experience allergic reactions, severe breathing difficulties, or chest pain. Immediate medical attention should be sought if these symptoms occur.\n\nMost side effects are mild and temporary. Rinsing the mouth after inhalation can significantly reduce the risk of oral infections caused by corticosteroids.\n\nPrecautions and Safety Advice\n\nBefore using AIRFLOWMAX F250, patients should inform their doctor if they have:\n\nHeart disease\n\nHigh blood pressure\n\nThyroid disorders\n\nDiabetes\n\nLiver problems\n\nPregnant or breastfeeding women should use this inhaler only under medical supervision. Patients should also avoid exceeding the prescribed dosage.\n\nConclusion\n\nAIRFLOWMAX F250 is an effective and reliable inhaler for managing chronic respiratory conditions such as asthma and COPD. By combining the bronchodilating effect of formoterol with the anti-inflammatory action of fluticasone, this inhaler provides comprehensive relief from breathing difficulties and helps maintain long-term respiratory health.\n",
"price": 309.0,
"discountamount": 93.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"COPD",
"asthma",
"relief",
"airways",
"symptoms",
"improved",
"breathing",
"daily use",
"Formoterol",
"Fluticasone",
"inflammation",
"bronchial muscles",
"long-term control",
"inhalation treatment",
"respiratory function",
"R/C AIRFLOW MAX F250",
"dual-action formulation",
"chronic respiratory conditions"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 902,
"imageuri": "https://productimages.withfloats.com/actual/6630e492043c15118d32d9ea.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6630e492043c15118d32d9ea.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-04-30T12:31:12.439Z",
"updatedon": "2026-03-09T11:04:13.583Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//formoterol-fluticasone-inhaler/902",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "AIRFLOWMAX F250",
"category": "ASTHMARANGE",
"tags": [
"formoterol fluticasone inhaler uses in asthma",
"formoterol fluticasone inhaler benefits for COPD",
"formoterol fluticasone inhaler dosage guide",
"formoterol fluticasone inhaler side effects",
"formoterol fluticasone inhaler brand names in india",
"buy formoterol fluticasone inhaler online",
"buy formoterol fluticasone inhaler online",
"buy formoterol fluticasone inhaler online",
"formoterol fluticasone inhaler supplier",
"who should use formoterol fluticasone inhaler",
"formoterol fluticasone inhaler benefits for lung function"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6912fc8c470ec71b0ac87646",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "mometasone furoate formoterol fumarate inhaler",
"description": "Mometasone Furoate and Formoterol Fumarate Inhaler is a combination respiratory medication formulated to provide effective and long-lasting control of asthma and chronic obstructive pulmonary disease (COPD). It combines two powerful active ingredients — Mometasone Furoate, a corticosteroid (anti-inflammatory), and Formoterol Fumarate, a long-acting bronchodilator (LABA). Together, these components help patients breathe easier by reducing airway inflammation and relaxing the muscles of the airways.\n\nThis dual-action inhaler is designed for maintenance therapy rather than immediate relief of acute symptoms. By targeting both inflammation and bronchial constriction, it provides a comprehensive approach to long-term respiratory management. Each inhalation delivers a precise dose to ensure consistent therapeutic results and improved lung function.\n\nMometasone Furoate and Formoterol Fumarate Inhaler is ideal for individuals who experience persistent asthma symptoms or airflow obstruction due to COPD, despite using single-ingredient inhalers.\n\nUses and Therapeutic Indications\n\nThe Mometasone Furoate and Formoterol Fumarate Inhaler is prescribed for the following respiratory conditions:\n\nAsthma (Bronchial Asthma):\n\nUsed for the long-term control and prevention of symptoms such as wheezing, breathlessness, and chest tightness.\n\nHelps reduce inflammation and airway hyperreactivity to prevent asthma attacks.\n\nChronic Obstructive Pulmonary Disease (COPD):\n\nHelps manage chronic bronchitis and emphysema by improving airflow and reducing airway inflammation.\n\nMaintenance Therapy:\n\nProvides ongoing treatment for patients whose symptoms are not adequately controlled by inhaled corticosteroids or bronchodilators alone.\n\nThis inhaler is not meant for emergency relief during sudden asthma attacks but rather as a daily maintenance therapy to control symptoms and prevent exacerbations.\n\nKey Benefits\n\nDual Mechanism of Action:\nCombines the anti-inflammatory power of Mometasone Furoate with the bronchodilating action of Formoterol Fumarate, offering complete respiratory control in one inhaler.\n\nReduces Airway Inflammation:\nMometasone Furoate suppresses the body’s inflammatory response, helping reduce swelling, mucus buildup, and irritation in the airways.\n\nLong-Lasting Bronchodilation:\nFormoterol provides fast and sustained relaxation of airway muscles, improving airflow and making breathing easier for up to 12 hours.\n\nImproves Lung Function:\nRegular use enhances pulmonary capacity, allowing patients to perform daily activities without breathing difficulty.\n\nFewer Asthma Exacerbations:\nReduces the frequency and severity of asthma attacks and flare-ups associated with COPD.\n\nConvenient Combination Therapy:\nProvides the benefits of two medications in a single device, improving compliance and simplifying treatment routines.\n\nBetter Symptom Control:\nProven to decrease wheezing, coughing, and nighttime symptoms, leading to better sleep and overall quality of life.\n\nRapid Onset of Action:\nFormoterol acts within minutes to ease breathing while Mometasone works continuously to maintain long-term inflammation control.\n\nPossible Side Effects\n\nWhile the Mometasone Furoate and Formoterol Fumarate Inhaler is well tolerated, some individuals may experience mild to moderate side effects, especially during the early phase of therapy. These include:\n\nThroat Irritation or Dryness\n\nHoarseness or Voice Changes\n\nHeadache or Dizziness\n\nCough or Upper Respiratory Tract Infections\n\nMuscle Cramps or Tremors\n\nPalpitations (Fast or Irregular Heartbeat)\n\nNausea or Mild Stomach Upset\n\nOral Thrush (Fungal Infection in the Mouth or Throat) – often preventable by rinsing the mouth with water after inhalation.\n\nPrecautions:\n\nThis inhaler is not a rescue medication; a short-acting bronchodilator should be kept on hand for sudden breathing attacks.\n\nRegular use is essential for best results — do not stop suddenly without consulting a doctor.\n\nPatients with heart conditions, hypertension, thyroid disorders, diabetes, or osteoporosis should use this medicine under medical supervision.\n\nAlways rinse the mouth after use to prevent fungal infections.\n\nConclusion\n\nThe Mometasone Furoate and Formoterol Fumarate Inhaler represents a modern, evidence-based approach to managing chronic respiratory conditions such as asthma and COPD. By combining a corticosteroid (to reduce airway inflammation) with a long-acting bronchodilator (to open the airways), it provides effective, dual-action relief that lasts throughout the day.\n\nRegular use of this inhaler helps improve breathing capacity, reduces symptom frequency, and enhances quality of life for individuals struggling with chronic lung diseases. It not only helps patients achieve better control over their respiratory symptoms but also reduces the need for emergency interventions and hospitalizations.",
"price": 360.0,
"discountamount": 108.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2199,
"imageuri": "https://productimages.withfloats.com/actual/6912fc8e6447ec42b9808956.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6912fc8e6447ec42b9808956.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-11-11T09:06:20.511Z",
"updatedon": "2026-03-14T08:49:38.354Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//mometasone-furoate-formoterol-fumarate-inhaler/2199",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "MONTASENSE F INH",
"category": "ASTHMA RANGE",
"tags": [
"Mometasone Furoate and Formoterol Fumarate Inhaler",
"respiratory medication",
"chronic obstructive pulmonary disease (COPD)",
"muscles of the airways.",
"respiratory control in one inhaler",
"Mometasone Furoate Formoterol Fumarate inhaler for asthma treatment",
"Mometasone Furoate Formoterol Fumarate dosage guide",
"Mometasone Furoate Formoterol Fumarate inhaler side effects",
"Best time to use Mometasone Furoate Formoterol Fumarate inhaler",
"Buy Mometasone Furoate Formoterol Fumarate inhaler online",
"Mometasone Furoate Formoterol Fumarate inhaler price per unit",
"Where to purchase Mometasone Furoate Formoterol Fumarate inhaler",
"Mometasone Furoate Formoterol Fumarate inhaler buy at the best price"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6863d70eaf0c9d1aa0c2d3e5",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "fluticasone furoate and vilanterol powder for inhalation",
"description": "FLUTICATONE VILO 200 is a combination inhalation therapy containing Fluticasone Furoate (200 mcg), a potent corticosteroid, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA). This fixed-dose inhalation powder is specially formulated to manage and prevent symptoms associated with chronic obstructive pulmonary disease (COPD) and asthma, helping patients breathe more easily and maintain better lung function.\n\nThis combination works synergistically—Fluticasone Furoate reduces inflammation and swelling in the airways, while Vilanterol relaxes the airway muscles, offering long-lasting bronchodilation. The once-daily dosing improves compliance and ensures consistent therapeutic effects throughout the day.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription combination medication used for long-term maintenance treatment of asthma and COPD. It is not a rescue medicine and should not be used to relieve sudden breathing problems.\n\nFluticasone Furoate 200 mcg: A highly effective corticosteroid that helps to reduce inflammation in the lungs.\n\nVilanterol 25 mcg: A bronchodilator that keeps airways open by relaxing muscles around them for up to 24 hours.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term treatment of moderate to severe asthma in adults and adolescents.\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.\n\nReduces the frequency of asthma attacks and COPD exacerbations.\n\nImproves overall lung function, quality of life, and exercise capacity in chronic airway diseases.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation uses\n\nSide Effects of Fluticasone Furoate and Vilanterol Powder for Inhalation\nWhile FLUTICATONE VILO 200 is generally well-tolerated, it may cause some side effects in certain individuals, especially during the initial phase of therapy. Common and less frequent side effects may include:\n\nHeadache\n\nHoarseness or voice changes\n\nSore throat\n\nCough or throat irritation\n\nFungal infection in the mouth (oral thrush)\n\nIncreased heart rate or palpitations\n\nMuscle cramps\n\nDizziness\n\nRespiratory tract infections\n\nSerious but rare effects include allergic reactions, paradoxical bronchospasm, and increased risk of pneumonia in COPD patients.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation side effects\n\nPrecautions Before Using\nDo not use FLUTICATONE VILO 200 for acute asthma or COPD attacks. Always carry a fast-acting inhaler.\n\nInform your doctor if you have a history of heart disease, hypertension, thyroid problems, liver disorders, or tuberculosis.\n\nRinse your mouth after each use to avoid oral thrush.\n\nUse the inhaler as prescribed, and do not exceed the recommended dose.\n\nNot recommended for use in children under 12 years unless prescribed.\n\nInform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.\n\nDrug Interactions\nCertain medications may affect the way FLUTICATONE VILO 200 works or increase the risk of side effects. Consult your doctor if you are taking:\n\nBeta-blockers (e.g., atenolol, propranolol)\n\nDiuretics (may increase the risk of hypokalemia)\n\nMAO inhibitors or tricyclic antidepressants (can enhance the effect of Vilanterol)\n\nAntifungal or antiviral medications (e.g., ketoconazole, ritonavir) that may increase corticosteroid levels\n\nOther long-acting beta agonists (LABAs) or inhaled corticosteroids\n\nWhat drugs interact with Fluticasone Furoate and Vilanterol?\nFluticasone Furoate and Vilanterol may interact with:\n\nStrong CYP3A4 inhibitors (like ritonavir, itraconazole) leading to increased steroid effects\n\nBeta-adrenergic blockers which may reduce the efficacy of vilanterol\n\nXanthine derivatives, diuretics, or digoxin, which may lead to heart rhythm disturbances when combined\n\nConclusion\nFLUTICATONE VILO 200 offers an effective, once-daily treatment for asthma and COPD by combining the anti-inflammatory power of Fluticasone Furoate 200 mcg and the long-acting bronchodilation of Vilanterol 25 mcg. It not only helps maintain clear airways but also improves your overall breathing comfort and quality of life. For optimal results, use the inhaler consistently and under your healthcare provider’s guidance.",
"price": 740.0,
"discountamount": 222.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"12 years",
"24 hours",
"increased risk",
"drugs interact",
"antiviral medications",
"recommended dose",
"airways open",
"reduce inflammation",
"acute asthma",
"asthma attacks",
"severe asthma",
"copd attacks",
"inhaler consistently",
"optimal results",
"breathing comfort",
"longacting bronchodilation",
"antiinflammatory power",
"inhaled corticosteroids",
"vilanterol antifungal",
"tricyclic antidepressants",
"taking betablockers",
"prescribed inform",
"tuberculosis rinse",
"headache hoarseness",
"initial phase",
"generally welltolerated",
"fluticatone vilo 200",
"exercise capacity",
"emphysema reduces",
"chronic bronchitis",
"relaxing muscles",
"rescue medicine",
"vilanterol relaxes",
"prevent symptoms",
"specially formulated",
"vilanterol 25 mcg",
"vilanterol powder",
"rare effects",
"ketoconazole ritonavir",
"healthcare provider",
"therapy common",
"potent corticosteroid",
"fluticasone furoate",
"side effects",
"lung function",
"vilanterol fluticasone furoate",
"copd exacerbations improves",
"inhalation fluticasone furoate",
"lung function quality",
"fixeddose inhalation powder",
"increase corticosteroid levels",
"fastacting inhaler inform",
"combination inhalation therapy",
"side effects consult",
"frequent side effects",
"inhalation longterm treatment",
"healthcare providers guidance",
"ritonavir itraconazole leading",
"highly effective corticosteroid",
"effective oncedaily treatment",
"heart rhythm disturbances",
"strong cyp3a4 inhibitors",
"hypokalemia mao inhibitors",
"atenolol propranolol diuretics",
"breastfeeding drug interactions",
"pregnant planning pregnancy",
"avoid oral thrush",
"sore throat cough",
"adolescents maintenance treatment",
"longterm maintenance treatment",
"prescription combination medication"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2140,
"imageuri": "https://productimages.withfloats.com/actual/686785bc0500f068046215ba.png",
"tileimageuri": "https://productimages.withfloats.com/tile/686785bc0500f068046215ba.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-01T12:39:42.59Z",
"updatedon": "2026-03-14T08:43:22.38Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//fluticasone-furoate-and-vilanterol-powder-for-inhalation/2140",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "FLUTICATONE VILO 200",
"category": "ASTHMARANGE",
"tags": [
"fluticasone furoate and vilanterol powder for inhalation",
"chronic obstructive pulmonary disease",
"lung function",
"Fluticasone Furoate and Vilanterol Powder",
"emphysema."
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6a685f3a5315456e18559082",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Acebrophylline and Erdosteine Tablets",
"description": "Acebrophylline and Erdosteine Tablets are a clinically trusted combination used in the management of chronic respiratory disorders associated with excessive mucus production, airway inflammation, and breathing difficulties. This dual-action formulation combines the bronchodilator and anti-inflammatory properties of Acebrophylline with the mucolytic and antioxidant benefits of Erdosteine, making it an effective treatment option for patients suffering from chronic obstructive pulmonary disease (COPD), chronic bronchitis, bronchial asthma, and other mucus-related respiratory conditions.\n\nAt [Your Company Name], we manufacture and supply premium-quality Acebrophylline and Erdosteine Tablets that comply with WHO-GMP standards and international pharmaceutical quality guidelines. Our formulations are trusted by healthcare professionals, hospitals, distributors, and pharmaceutical companies seeking reliable respiratory medicines.\n\nComposition\nEach film-coated tablet typically contains:\n\nAcebrophylline – 200 mg\nErdosteine – 300 mg\nComposition can be customized based on customer requirements and regulatory approvals.\n\nHow Acebrophylline and Erdosteine Tablets Work\nThe combination provides comprehensive respiratory support through complementary mechanisms.\n\nAcebrophylline\nAcebrophylline acts as a bronchodilator and anti-inflammatory agent. It helps relax bronchial muscles, widens the airways, improves airflow, and reduces inflammation, making breathing easier for patients with chronic respiratory diseases.\n\nErdosteine\nErdosteine is a powerful mucolytic agent that reduces the thickness and stickiness of mucus. It facilitates easier expectoration, reduces coughing, and provides antioxidant protection against airway damage caused by inflammation.\n\nTogether, these ingredients improve lung function, reduce respiratory symptoms, and enhance patient comfort.\n\nKey Benefits of Acebrophylline and Erdosteine Tablets\nHelps improve breathing by relaxing bronchial muscles\nEffectively reduces thick mucus accumulation\nSupports easier mucus clearance from the lungs\nReduces chronic cough and chest congestion\nHelps manage COPD and chronic bronchitis symptoms\nProvides antioxidant protection to respiratory tissues\nImproves oxygen exchange and lung function\nEnhances quality of life in patients with chronic respiratory disorders\nSuitable for long-term respiratory disease management under medical supervision\nMedical Uses of Acebrophylline and Erdosteine Tablets\nHealthcare professionals commonly prescribe Acebrophylline and Erdosteine Tablets for:\n\nChronic Obstructive Pulmonary Disease (COPD)\nChronic Bronchitis\nBronchial Asthma\nRespiratory Tract Infections with Excessive Mucus\nChronic Productive Cough\nAirway Inflammation\nBronchiectasis\nSmoking-related Respiratory Conditions\nThese tablets should always be used under the supervision of a qualified healthcare professional.\n\nAdvantages of the Acebrophylline and Erdosteine Combination\nThe combination therapy offers several clinical advantages over single-drug treatment.\n\nDual Mechanism of Action\nIt simultaneously opens the airways while reducing mucus thickness, providing comprehensive respiratory relief.\n\nImproved Lung Function\nPatients experience better airflow and enhanced breathing comfort due to bronchodilation and mucus clearance.\n\nReduced Frequency of Exacerbations\nRegular use, as prescribed, may help decrease episodes of worsening respiratory symptoms in chronic lung diseases.\n\nBetter Patient Compliance\nA fixed-dose combination simplifies treatment by reducing the need for multiple medications.\n\nRecommended Dosage\nThe dosage of Acebrophylline and Erdosteine Tablets should be determined by a registered healthcare provider based on the patient's age, condition, and medical history.\n\nGeneral recommendations include:\n\nTake the tablet after meals with water.\nSwallow whole without crushing or chewing.\nFollow the prescribed duration of therapy.\nDo not exceed the recommended dose.\nPossible Side Effects\nLike all medicines, Acebrophylline and Erdosteine Tablets may cause side effects in some individuals.\n\nCommon side effects include:\n\nNausea\nStomach discomfort\nHeadache\nDizziness\nMild diarrhea\nDry mouth\nGastric irritation\nSeek immediate medical attention if severe allergic reactions, breathing difficulty, or persistent adverse effects occur.\n\nPrecautions\nBefore using Acebrophylline and Erdosteine Tablets, patients should inform their healthcare provider if they have:\n\nLiver disease\nKidney impairment\nGastric ulcer\nHeart disease\nPregnancy or breastfeeding\nKnown allergy to methylxanthines or Erdosteine\nAvoid self-medication and always follow professional medical advice.\n\nStorage Instructions\nStore below 25°C in a cool and dry place.\nProtect from direct sunlight and moisture.\nKeep out of reach of children.\nDo not use after the expiry date.\nWhy Choose Our Acebrophylline and Erdosteine Tablets?\nWe are committed to delivering pharmaceutical products that meet international quality standards.\n\nOur advantages include:\n\nWHO-GMP Certified Manufacturing\nISO Certified Production Facilities\nStringent Quality Control\nDCGI-Compliant Manufacturing\nCompetitive Pricing\nBulk Supply Capability\nThird-Party Manufacturing Services\nPrivate Label Packaging\nTimely Global Deliveries\nCustom Packaging Solutions\nWe serve pharmaceutical distributors, hospitals, government tenders, exporters, wholesalers, and healthcare institutions worldwide.\n\nFrequently Asked Questions (FAQs)\n1. What are Acebrophylline and Erdosteine Tablets used for?\nAcebrophylline and Erdosteine Tablets are primarily used to treat respiratory conditions such as COPD, chronic bronchitis, asthma, and other diseases associated with excessive mucus production and airway obstruction.\n\n2. How do Acebrophylline and Erdosteine Tablets work?\nAcebrophylline relaxes the bronchial muscles and reduces inflammation, while Erdosteine breaks down thick mucus, making it easier to remove from the lungs.\n\n3. Can Acebrophylline and Erdosteine Tablets treat chronic cough?\nYes. These tablets help relieve chronic productive cough by reducing mucus viscosity and improving airway clearance when prescribed by a healthcare professional.\n\n4. Are Acebrophylline and Erdosteine Tablets safe for long-term use?\nThey may be prescribed for long-term management of chronic respiratory diseases, but treatment duration should always be determined by a physician.\n\n5. Can these tablets be used for asthma?\nYes. Doctors may prescribe Acebrophylline and Erdosteine Tablets as part of asthma management when mucus accumulation and airway inflammation are significant.\n\n6. Do Acebrophylline and Erdosteine Tablets have side effects?\nMost side effects are mild and temporary, including nausea, headache, dizziness, stomach upset, and dry mouth. Serious reactions are uncommon but require immediate medical attention.\n\n7. Should Acebrophylline and Erdosteine Tablets be taken before or after food?\nThey are generally recommended after meals to reduce the risk of stomach irritation. Follow your doctor's advice regarding dosage and timing.\n\n8. Can smokers use Acebrophylline and Erdosteine Tablets?\nYes. Physicians often prescribe them to smokers suffering from chronic bronchitis, COPD, or mucus-related respiratory disorders.\n\n9. Are Acebrophylline and Erdosteine Tablets available for third-party manufacturing?\nYes. We offer third-party manufacturing, private labeling, customized packaging, and bulk pharmaceutical supply for domestic and international markets.\n\n10. Why buy Acebrophylline and Erdosteine Tablets from us?\nOur products are manufactured in WHO-GMP-certified facilities using premium-quality raw materials, strict quality control processes, competitive pricing, and reliable global distribution, making us a trusted pharmaceutical manufacturing partner.\n\nThis version is optimized for buyer intent, includes keyword-rich headings and FAQs designed for Google Search and voice search, and naturally targets the primary keyword “Acebrophylline and Erdosteine Tablets” throughout the content without excessive keyword stuffing.",
"price": 360.0,
"discountamount": 108.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2487,
"imageuri": "https://productimages.withfloats.com/actual/6a685f3db435445dbdc3d469.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a685f3db435445dbdc3d469.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-28T07:50:18.551Z",
"updatedon": "2026-07-28T07:50:18.551Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//acebrophylline-and-erdosteine-tablets/2487",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "STERIPHYLLIN ERDO",
"category": "ASTHMA RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}